Stepped Care Model for the Wider Dissemination of Cognitive-Behavioural Therapy for Insomnia Among Cancer Patients (Stepped Care)
Insomnia
About this trial
This is an interventional treatment trial for Insomnia focused on measuring stepped care model, insomnia, cancer, cognitive-behavioural therapy, self-help treatment, web-based intervention, non-inferiority design, cost-effectiveness
Eligibility Criteria
Inclusion Criteria:
- have received a diagnosis of non-metastatic cancer (any type) in the past -18 months
- to have an ISI score > 7
- to be aged between 18 and 75 years old
- to be readily able to read and understand French
Exclusion Criteria:
- having a life expectancy < 1 year
- having a severe psychiatric disorder (e.g., psychotic, substance use, severe depressive disorder)
- having severe cognitive impairments (e.g., diagnosis of Parkinson's disease, dementia, or Mini-Mental State Examination score < 24)
- having received a formal diagnosis for another sleep disorder (e.g., obstructive sleep apnea, periodic limb movement disorder)
- shift work in the past 3 months or in the next 12 months
- to have received a CBT for insomnia in the past
Sites / Locations
- Centre de recherche de L'Hôtel-Dieu de Québec
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Professionally Administered CBT-I (Standard Care)
Stepped Care CBT-I
Patients (n = 59) assigned to this group will receive 6 weekly sessions of cognitive-behavioral therapy for insomnia (CBT-I) of approximately 50 minutes, offered individually by a licensed psychologist with significant experience (at least 2 years) in the administration of CBT-I with cancer patients.
Patients having an ISI score > 7 but < 15 (n = 65), will all receive first a web-based CBT-I for six weeks. Each week, the patients will first have to read written information on the website, and then watch a video capsule (duration between 5 and 20 min each). Patients with an ISI score > 14 (n = 53) will receive six weekly sessions of CBT-I administered individually by a professional.